Altered Cortisol Metabolism in Polycystic Ovary Syndrome: Insulin Enhances 5α-Reduction But Not the Elevated Adrenal Steroid Production Rates
The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Abstract
Androgen excess in women with polycystic ovary syndrome (PCOS) may be ovarian and/or adrenal in origin, and one proposed contributing mechanism is altered cortisol metabolism. Increased peripheral metabolism of cortisol may occur by enhanced inactivation of cortisol by 5α-reductase (5α-R) or impaired reactivation of cortisol from cortisone by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) resulting in decreased negative feedback suppression of ACTH secretion maintaining normal plasma cortisol concentrations at the expense of androgen excess. We have tested whether any enzyme dysregulation was related to circulating insulin or androgen concentrations in women with PCOS and have sought to clarify their relationship with obesity. First, to avoid obesity-related effects on cortisol metabolism, 18 lean women with PCOS were compared with 19 lean controls who were closely matched for body mass index (BMI). Second, the impact of obesity was studied in a cross-section of 42 PCOS women of a broad range of BMI. We measured 24-h urinary excretion of steroid metabolites by gas chromatography/mass spectrometry and fasting metabolic and hormone profiles. Urinary excretion of androgens [androsterone (P = 0.003), etiocholanolone (P = 0.02), and C19 steroid sulfates (P = 0.009)], cortisone metabolites [tetrahydrocortisone (THE) (P = 0.02), α-cortolone (P < 0.001), β-cortol + β-cortolone (P < 0.001), cortolones (P < 0.001), and E metabolites (P < 0.001)], and TCM (P = 0.002) were raised in lean PCOS subjects when compared with controls. A significantly higher 5α-tetrahydrocortisol (5α-THF)/5β-THF ratio (P = 0.04) and a significantly lower α-THF + THF + α-cortol/THE + cortolones ratio (P = 0.01) were found in lean PCOS women compared with lean controls, indicating both enhanced 5α-R and reduced 11β-HSD1 activities. A decreased THE/cortolones ratio (P = 0.03) was also found in lean PCOS women compared with lean controls, indicating increased 20 α/β-HSD activity. In the group of 42 PCOS subjects, measures of 5α/5β reduction were positively correlated with the homeostasis model insulin resistance index (HOMA-R): α-THF/THF and HOMA-R (r = 0.34; P = 0.03), androsterone/etiocholanolone and HOMA-R (r = 0.32; P = 0.04), and total 5α /total 5β and HOMA-R (r = 0.37; P = 0.02). A positive correlation was also found between measures of 5α-R and BMI (r = 0.37; P = 0.02). No correlation was found between measures of 11β-HSD1 activity and indices of insulin sensitivity or BMI. We have demonstrated that there is an increased production rate of cortisol and androgens as measured in vivo in lean PCOS women. Insulin seems to enhance 5α reduction of steroids in PCOS but was not associated with the elevated cortisol production rate. The changes in 5α-R, 11β-HSD1, and 20α/β-HSD enzyme activities observed in PCOS may contribute to the increased production rates of cortisol and androgens, supporting the concept of a widespread dysregulation of steroid metabolism. This dysregulation does not seem to be the primary cause of PCOS because no correlation was found between serum androgen levels or urinary excretion of androgens with measurements of either 5α-R or 11β-HSD1 activities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reduced cortisol levels cause inadequate negative feedback on the hypothalamic–pituitary–adrenal axis with increased pituitary ACTH synthesis and stimulation of adrenal steroidogenesis [24].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [24]
In the citing paper
“These side effects are also accentuated by the effect of estrogen to increase cortisol binding globulin (CBG) and stimulate ACTH synthesis to maintain adequate free cortisol [24].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [24]
Citations
Cites
Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989) · Diabetes · doi:10.2337/diab.38.9.1165 · Cited by 1,967
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714
Insulin resistance in nonobese patients with polycystic ovarian disease
CHANG, R. J., NAKAMURA, R. M., JUDD, H. L., & KAPLAN, S. A. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-2-356 · Cited by 704
Tissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655
Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome
Dunaif, A., Segal, K. R., Shelley, D. R., Green, G., Dobrjansky, A., & Licholai, T. (1992) · Diabetes · doi:10.2337/diab.41.10.1257 · Cited by 546
Morales, A. J. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2854 · Cited by 455
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., & Shackleton, C. H. L. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.3.5538 · Cited by 398
Rask, E., Walker, B. R., Söderberg, S., Livingstone, D. E. W., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 386
Cited by
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Self-citationObesity and polycystic ovary syndrome
Barber, T. M., McCarthy, M. I., Wass, J. A. H., & Franks, S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02587.x · Cited by 631
Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041454 · Cited by 521
“The enhanced inactivation of cortisol by 5alpha-reductase (5alpha-R), or the impaired reactivation of cortisol from cortisone by 11 beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), may cause increased peripheral cortisol metabolism, which results in less negative feedback suppression of adrenocorticotropic horm…”
BackgroundVan Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02067.x · Cited by 439
Armanini, D., Boscaro, M., Bordin, L., & Sabbadin, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084110 · Cited by 324
“These side effects are also accentuated by the effect of estrogen to increase cortisol binding globulin (CBG) and stimulate ACTH synthesis to maintain adequate free cortisol [24].”
BackgroundPolycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications
Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294
Urinary markers of adrenarche: reference values in healthy subjects, aged 3–18 years
Remer, T., Boye, K. R., Hartmann, M. F., & Wudy, S. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1571 · Cited by 193
“In polycystic ovary syndrome, for example, enhanced peripheral 5 -Red activity seems to be a metabolic characteristic occurring together with an at least partly adrenal-induced hyperandrogenism (19, 20).”
BackgroundGoodarzi, M. O., Carmina, E., & Azziz, R. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.06.003 · Cited by 188
“More recent studies have shown that 11b-HSD1 overactivity in PCOS women is determined mainly by the obesity [82,87], while exaggerated 5a-RA activity is partially dependent on excessive body weight [87,88].”
BackgroundGlintborg, D., & Andersen, M. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903247873 · Cited by 159
“Several studies found decreased 11b-HSD1 activity in patients with PCOS [23], thus probably causing increased metabolic clearance of cortisol.”
BackgroundResultHormonal alterations in PCOS and its influence on bone metabolism
Krishnan, A., & Muthusami, S. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0405 · Cited by 158
Childhood Obesity and Its Impact on the Development of Adolescent PCOS
Anderson, A., Solorzano, C., & McCartney, C. (2014) · Seminars in Reproductive Medicine · doi:10.1055/s-0034-1371092 · Cited by 146
The adrenal and polycystic ovary syndrome
Yıldız, B. O., & Azziz, R. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9054-0 · Cited by 149
“The increased metabolism of cortisol may be due to enhanced inactivation of this steroid by 5αRA [60, 61] or impaired reactivation of cortisol from cortisone by 11β-HSD1 [59, 60].”
BackgroundTomlinson, J. W., Finney, J., Gay, C., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0495 · Cited by 131
“Moreover, within a cohort of patients with PCOS, 5 R activity correlates with insulin resistance (48).”
BackgroundAre There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?
Stener-Victorin, E., Holm, G., Labrie, F., Nilsson, L., Janson, P. O., & Ohlsson, C. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1908 · Cited by 126
Di Lorenzo, M., Cacciapuoti, N., Lonardo, M. S., Nasti, G., Gautiero, C., Belfiore, A., Guida, B., & Chiurazzi, M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00479-8 · Cited by 108
Increased 5α-Reductase Activity and Adrenocortical Drive in Women with Polycystic Ovary Syndrome
Vassiliadi, D. A., Barber, T. M., Hughes, B. A., McCarthy, M. I., Wass, J. A. H., Franks, S., Nightingale, P., Tomlinson, J. W., Arlt, W., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0837 · Cited by 110
Wudy, S. A., Hartmann, M. F., & Remer, T. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2006 · Cited by 101
Livingstone, D. E. W., Barat, P., Di Rollo, E. M., Rees, G. A., Weldin, B. A., Rog-Zielinska, E. A., MacFarlane, D. P., Walker, B. R., & Andrew, R. (2015) · Diabetes · doi:10.2337/db14-0249 · Cited by 100
Meditation interventions efficiently reduce cortisol levels of at-risk samples: A meta-analysis
Koncz, A., Demetrovics, Z., & Takacs, Z. K. (2021) · Health Psychology Review · doi:10.1080/17437199.2020.1760727 · Cited by 94
Adipose tissue and reproduction in women
BOHLER, H. C. L., Mokshagundam, S. L., & Winters, S. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.03.079 · Cited by 110
Tomlinson, J. W., Finney, J., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0094 · Cited by 91
Goodarzi, M. O., Shah, N. A., Antoine, H. J., Pall, M., Guo, X., & Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0227 · Cited by 90
Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity
Roberge, C., Carpentier, A. C., Langlois, M.-F., Baillargeon, J.-P., Ardilouze, J.-L., Maheux, P., & Gallo-Payet, N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00516.2007 · Cited by 89
Cho, H.-J., Kim, J.-D., Lee, W., Chung, B. C., & Choi, M. H. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.10.059 · Cited by 86
Androgens and the Regulation of Adiposity and Body Fat Distribution in Humans
Tchernof, A., Brochu, D., Maltais‐Payette, I., Mansour, M. F., Marchand, G. B., Carreau, A., & Kapeluto, J. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170009 · Cited by 86
Stimson, R. H., Johnstone, A. M., Homer, N. Z. M., Wake, D. J., Morton, N. M., Andrew, R., Lobley, G. E., & Walker, B. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0692 · Cited by 83
Linking Stress and Infertility: A Novel Role for Ghrelin
Sominsky, L., Hodgson, D. M., McLaughlin, E. A., Smith, R., Wall, H. M., & Spencer, S. J. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1133 · Cited by 82
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
Kempegowda, P., Melson, E., Manolopoulos, K. N., Arlt, W., & O’Reilly, M. W. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820934319 · Cited by 70
Li, Q., Du, J., Feng, R., Xu, Y., Wang, H., Sang, Q., Xing, Q., Zhao, X., Jin, L., He, L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3685 · Cited by 67
Polycystic Ovary Syndrome: Pathophysiology and Controversies in Diagnosis
Fahs, D., Salloum, D., Nasrallah, M., & Ghazeeri, G. S. (2023) · Diagnostics · doi:10.3390/diagnostics13091559 · Cited by 108
Harmful effects of functional hypercortisolism: a working hypothesis
Tirabassi, G., Boscaro, M., & Arnaldi, G. (2013) · Endocrine · doi:10.1007/s12020-013-0112-y · Cited by 77
“PCOS [184–186]”
Wu, C., Jiang, F., Wei, K., & Jiang, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-26210-0 · Cited by 71
Ovarian and Adrenal Hyperandrogenism
CARMINA, E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.011 · Cited by 53
5α-Reduced glucocorticoids: a story of natural selection
Nixon, M., Upreti, R., & Andrew, R. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0318 · Cited by 69
Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women
Tosi, F., Negri, C., Brun, E., Castello, R., Faccini, G., Bonora, E., Muggeo, M., Toscano, V., & Moghetti, P. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0782 · Cited by 52
A guide to understanding the steroid pathway: New insights and diagnostic implications
Greaves, R. F., Jevalikar, G., Hewitt, J. K., & Zacharin, M. R. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.07.017 · Cited by 52
Lerchbaum, E., Theiler‐Schwetz, V., Giuliani, A., Pieber, T. R., & Obermayer-Pietsch, B. M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.07.1057 · Cited by 54
Margiotta‐Casaluci, L., Hannah, R. E., & Sumpter, J. P. (2012) · Aquatic Toxicology · doi:10.1016/j.aquatox.2012.12.003 · Cited by 52
5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
Nasiri, M., Nikolaou, N., Parajes, S., Krone, N. P., Valsamakis, G., Mastorakos, G., Hughes, B., Taylor, A., Bujalska, I. J., Gathercole, L. L., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1149 · Cited by 50
Torchen, L. C., Idkowiak, J., Fogel, N. R., O'Neil, D. M., Shackleton, C. H. L., Arlt, W., & Dunaif, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3926 · Cited by 49
Is the adrenal cortex a target for gonadotropins?
Bernichtein, S., Alevizaki, M. K., & Huhtaniemi, I. T. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.06.003 · Cited by 55
Lee, S. H., Kang, S. M., Choi, M. H., Lee, J., Park, M. J., Kim, S. H., Lee, W., Hong, J., & Chung, B. C. (2013) · Reproductive Toxicology · doi:10.1016/j.reprotox.2013.03.008 · Cited by 50
Dhayat, N. A., Marti, N., Kollmann, Z., Troendle, A., Bally, L., Escher, G., Grössl, M., Ackermann, D., Ponte, B., Pruijm, M., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0203903 · Cited by 43
Raffaelli, A., Saba, A., Vignali, E., Marcocci, C., & Salvadori, P. A. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.11.011 · Cited by 46
Baravalle, C., Salvetti, N. R., Mira, G., Lorente, J., & Ortega, H. H. (2007) · Physiological Research · doi:10.33549/physiolres.930870 · Cited by 35
Mohammadi, S., Monazzami, A., & alavimilani, S. (2023) · BMC Sports Science Medicine and Rehabilitation · doi:10.1186/s13102-023-00653-z · Cited by 51
“Therefore, exercise helps regulate the activity of this hormone by reducing the activity of these enzymes and reducing insulin levels and increasing insulin sensitivity [29].”
Background5α-reductase activity in women with polycystic ovary syndrome: a systematic review and meta-analysis
Wu, C., Wei, K., & Jiang, Z. (2017) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-017-0242-9 · Cited by 36
“In some previous studies, 5αreductase was positively correlated with body weight in adult women with PCOS [14, 15].”
BackgroundMethodResultMüssig, K., Remer, T., Haupt, A., Gallwitz, B., Fritsche, A., Häring, H., & Maser‐Gluth, C. (2008) · Obesity · doi:10.1038/oby.2008.218 · Cited by 38
“Global activity of 11β-HSD1 was conventionally assessed by the ratio (5α-THF + THF)/ THE (22) and the net balance between 5α- and 5β-reductase by the ratio 5α-THF/THF (23,24).”
MethodInhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 in Obesity
Wake, D. J., & Walker, B. R. (2006) · Endocrine · doi:10.1385/endo:29:1:101 · Cited by 37
Svendsen, P. F., Madsbad, S., Nilas, L., Paulsen, S. K., & Pedersen, S. B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.165 · Cited by 33
Relative adrenal insufficiency in mice deficient in 5α-reductase 1
Livingstone, D. E. W., Rollo, E. M. D., Yang, C., Lucy, C., Mathews, J. A., Kara, M., Hughes, K. A., Kenyon, C. J., Walker, B. R., & Andrew, R. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0563 · Cited by 37
“Upregulation of 5a-reductase has been invoked to explain adrenal androgen excess in polycystic ovary syndrome (Stewart et al. 1990, Fassnacht et al. 2003, Tsilchorozidou et al. 2003).”
BackgroundGambineri, A., Fanelli, F., Tomassoni, F., Munarini, A., Pagotto, U., Andrew, R., Walker, B. R., & Pasquali, R. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-1030 · Cited by 30
Thiazolinedione treatment in PCOS – an update
Glintborg, D., & Andersen, M. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.491572 · Cited by 34
“5a-reductase activity correlated with insulin resistance in PCOS [56] and insulin sensitising treatment was followed by decreased 5areductase activity in animal studies [57] and in PCOS [22].”
BackgroundLivingstone, D. E. W., Grassick, S. L., Currie, G. L., Walker, B. R., & Andrew, R. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0003 · Cited by 34
“Previous reports in both humans and rats support the notion that up-regulation of 5aR1 is secondary to the development of insulin resistance/hyperinsulinaemia and is reversible on treatment (Tsilchorozidou et al. 2003, Livingstone et al. 2005, Tomlinson et al. 2008).”
BackgroundJeon, H., Choi, Y., Brännström, M., Akin, J. W., Curry, T. E., & Jo, M. (2023) · Human Reproduction · doi:10.1093/humrep/dead017 · Cited by 34
Cuzzola, A. R., Mazzini, F., & Petri, A. (2014) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.02.003 · Cited by 29
Silva, R. D. C., Pardini, D., & Kater, C. E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200014 · Cited by 74
Valsamakis, G., Lois, K., Kumar, S., & Mastorakos, G. P. (2013) · HORMONES · doi:10.1007/bf03401302 · Cited by 30
Graupp, M., Wehr, E., Schweighofer, N., Pieber, T. R., & Obermayer-Pietsch, B. M. (2011) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2011.03.026 · Cited by 36
“Elevated levels of dihydrotestosterone and other metabolites produced by 5a-reductase were found thereby [19–21].”
BackgroundGambineri, A., Forlani, G., Munarini, A., Tomassoni, F., Cognigni, G. E., Ciampaglia, W., Pagotto, U., Walker, B. R., & Pasquali, R. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346454 · Cited by 33
Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues
Mansour, M. F., Pelletier, M., & Tchernof, A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.02.003 · Cited by 32
Louwers, Y. V., de Jong, F. H., van Herwaarden, N. A. A., Stolk, L., Fauser, B. C. J. M., Uitterlinden, A. G., & Laven, J. S. E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1976 · Cited by 26
Rogers, S. L., Hughes, B. A., Jones, C. A., Freedman, L., Smart, K., Taylor, N., Stewart, P. M., Shackleton, C. H. L., Krone, N. P., Blissett, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3254 · Cited by 25
Kalliokoski, O., Teilmann, A. C., Abelson, K., & Hau, J. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.12.008 · Cited by 26
Glintborg, D., Hermann, A. P., Hagen, C., Jensen, L. T., Frystyk, J., Bennett, P., Flyvbjerg, A., & Andersen, M. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.12.082 · Cited by 26
Nikolaou, N., Hodson, L., & Tomlinson, J. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105808 · Cited by 30
Michael, A. E., Glenn, C., Wood, P. J., Webb, R. J., Pellatt, L., & Mason, H. D. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1385 · Cited by 24
Increased A‐ring Reduction of Glucocorticoids in Obese Zucker Rats: Effects of Insulin Sensitization
Livingstone, D. E. W., McInnes, K. J., Walker, B. R., & Andrew, R. (2005) · Obesity Research · doi:10.1038/oby.2005.186 · Cited by 23
Laforest, S., Pelletier, M., Denver, N., Poirier, B., Nguyen, S., Walker, B. R., Durocher, F., Homer, N. Z. M., Diorio, C., Andrew, R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz268 · Cited by 23
Thyroid disorders in obese patients. Does insulin resistance make a difference?
Răcătăianu, N., Leach, N. V., Bondor, C. I., Mârza, S., Moga, D. C., Valea, A., & Ghervan, C. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000306 · Cited by 32
“Patients with obesity may display enhanced inactivation of cortisol by 5α-reductase or impaired reactivation of cortisol from cortisone by 11β-hydroxysteroid dehydrogenase type 1, resulting in activation of the HPA axis (34,35).”
BackgroundKosicka, K., Siemiątkowska, A., Pałka, D., Szpera-Goździewicz, A., Bręborowicz, G. H., & Główka, F. K. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.03.039 · Cited by 26
Infertility and cortisol: a systematic review
Karunyam, B. V., Karim, A., Mohamed, I. N., Ugusman, A., Mohamed, W. M. Y., Faizal, A. M., Abu, M. A., & Kumar, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1147306 · Cited by 41
Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome
Blumenfeld, Z., Kaidar, G., Zuckerman‐Levin, N., Dumin, E., Knopf, C. F., & Hochberg, Z. (2016) · Clinical Medicine Insights Reproductive Health · doi:10.4137/cmrh.s35567 · Cited by 24
Nasiri, M., Monazzami, A., alavimilani, S., & Asemi, Z. (2022) · PubMed Central · doi:10.22074/ijfs.2022.551096.1279 · Cited by 35
Hu, M., Zhang, Y., Guo, X., Jia, W., Liu, G., Zhang, J., Cui, P., Li, J., Li, W., Wu, X., et al. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116681 · Cited by 23
Kulshreshtha, B., Marumudi, E., Khurana, M. L., Kriplani, A., Kinra, G., Gupta, D. K., Kucheria, K., Khadgawat, R., Gupta, N., Seith, A., et al. (2008) · Gynecological Endocrinology · doi:10.1080/09513590801945230 · Cited by 23
“These androgen levels are much higher than those observed in patients with PCOS (usually less than 2 ng/ml), a common clinical condition associated with poor ovarian functions.”
BackgroundCortisol and the polycystic ovary syndrome
Pasquali, R., & Gambineri, A. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.42 · Cited by 23
Honour, J. W., Conway, E., Hodkinson, R., & Lam, F. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.02.013 · Cited by 20
Self-citationEmami, N., Moini, A., Yaghmaei, P., Akbarinejad, V., Shahhoseini, M., & علیزاده, د. ع. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03957-5 · Cited by 19
Dumesic, D. A., Turcu, A. F., Liu, H., Grogan, T., Abbott, D. H., Lu, G., Dharanipragada, D., & Chazenbalk, G. D. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad079 · Cited by 20
“Moreover, a trend toward reduced serum cortisol to cortisone ratio in the present women with PCOS agrees with decreased HSD11ß1 activity in other normal-weight women with PCOS [33], and with increased urinary excretion of 11-oxo to 11-hydroxy metabolites of cortisol in nonobese women with PCOS [34].”
BackgroundProbo, M., Comin, A., Cairoli, F., Faustini, M., Kindahl, H., Amicis, I. D., & Veronesi, M. C. (2010) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.2010.01688.x · Cited by 20
Fraser, R., Gower, D. B., Honour, J. W., Ingram, M. C., Kicman, A. T., Makin, H. L. J., & Stewart, P. M. (2010) · Springer eBooks · doi:10.1023/b135931_5 · Cited by 19
Self-citationRemer, T., Dimitriou, T., & Maser‐Gluth, C. (2008) · Journal of Nutrition · doi:10.1093/jn/138.2.426s · Cited by 17
Liang, Q., Wang-yan-jun, X., Hong, Q., Yang, C. X. L., Ma, Z.-C., Wang, Y., Tan, H.-L., Tang, X., & Gao, Y. (2015) · European Journal of Mass Spectrometry · doi:10.1255/ejms.1395 · Cited by 15
Milutinović, D. V., Teofilović, A., Veličković, N. A., Brkljačić, J. M., Jelača, S., Djordjevic, A. D., & Μacut, D. (2021) · Endocrine · doi:10.1007/s12020-020-02600-1 · Cited by 19
Işık, S., Özcan, H. N., Özuğuz, U., Berker, D. S., Tütüncü, Y., Akbaba, G., & Güler, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04210.x · Cited by 17
Shi, M., Li, X., Xing, L., Li, Z., Zhou, S., Wang, Z., Zou, X., She, Y., Zhao, R., & Qin, D. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121556 · Cited by 26
Hydrohysteroid Dehydrogenases – Biological Role and Clinical Importance – Review
Atanassova, N. N., & Koev, Y. (2012) · InTech eBooks · doi:10.5772/54149 · Cited by 23
Casals, G., Marcos, J., Pozo, Ó. J., Aguilera, P., Herrero, C., & To‐Figueras, J. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.03.001 · Cited by 15
Tsilchorozidou, T., Mohamed‐Ali, V., & Conway, G. S. (2009) · Hormone Research in Paediatrics · doi:10.1159/000197871 · Cited by 16
“As metformin seems to be implicated in weight loss in women with PCOS, it provides a model to study adipose tissue-derived cytokine regulation. We hypothesized that some of the benefit from metformin in women with PCOS may be mediated by mobilization of visceral fat and subsequent fall in circulating IL-6 and CRP conc…”
MethodSelf-citationSharma, A., Wigham, J. R., & Veldhuis, J. D. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12108 · Cited by 16
“These outcomes are consistent with earlier studies showing that decreased insulin availability is associated with diminished ACTH efficacy (14, 34), increased cortisol metabolism via 5-alpha reductase, and attenuated cortisol synthesis via 11-beta hydroxysteroid dehydrogenase type I, culminating in lower total cortiso…”
ResultPost-dexamethasone serum copeptin corresponds to HPA axis responsiveness in human obesity
Schinke, C., Hesse, S., Stoppe, M., Meyer, K., Schmidt, E., Orthgieß, J., Bechmann, L., Bresch, A., Rullmann, M., Luthardt, J., et al. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.004 · Cited by 15
Dineen, R., Martin‐Grace, J., Ahmed, K. M. S., TAYLOR, A. E. R., Shaheen, F., Schiffer, L., Gilligan, L. C., Lavery, G. G., Frizelle, I. M., Gunness, A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad370 · Cited by 14
Padder, K. A., Jahan, N., Yousuf, M., Shah, I. A., Bhat, G. A., Khurshid, R., Zargar, M. H., & Ganie, M. A. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01734-y · Cited by 18
“Adrenal hyperandrogenism has also been linked to increased peripheral cortisol metabolism [52].”
Hou, M., Ji, C., Wang, J., Liu, Y., Sun, B., Guo, M., Burén, J., & Li, X. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0191 · Cited by 12
“…of Endocrinology (2012) 215, 119–127 Downloaded from Bioscientifica.com at 12/21/2018 11:02:47PM via free access or insulin-resistant animals (Livingstone et al. 2000) and humans (Tsilchorozidou et al. 2003, Baudrand et al. 2011) have revealed higher expression of hepatic 5a-reductase.”
BackgroundEffect of bilateral oophorectomy on adrenocortical function in women with polycystic ovary syndrome
Azziz, R., Chang, W. Y., Stanczyk, F. Z., & Woods, K. S. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.10.016 · Cited by 12
Thangaraj, S. V., Zeng, L., Pennathur, S., Lea, R. G., Sinclair, K. D., Bellingham, M., Evans, N. P., Auchus, R. J., & Padmanabhan, V. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.165674 · Cited by 13
Μacut, D., Milutinović, D. V., Antić, I. B., Matić, G. M., Brkljačić, J. M., Panidis, D., Petakov, M. S., Spanos, N., Bjekić, J., Stanojlović, O. P., et al. (2009) · Endocrine · doi:10.1007/s12020-009-9277-9 · Cited by 11
Metadata
- Authors
- Tsilchorozidou, T., Honour, J. W., & Conway, G. S.
- Affiliations
- University College London (GB)
- Corresponding author
- Conway, Gerard S.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-12-01
- Volume
- 88
- Issue
- 12
- Pages
- 5907-5913
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2167416408
- Cited by
- 155
- References
- 40
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 12 · 2022: 6 · 2021: 6 · 2020: 2 · 2019: 6 · 2018: 8 · 2017: 7 · 2016: 6 · 2015: 6 · 2014: 12 · 2013: 12 · 2012: 6
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- polycystic ovary syndrome, cortisol metabolism, 5α-reductase, 11β-hydroxysteroid dehydrogenase type 1, insulin, hyperandrogenism, adrenal steroidogenesis, obesity, urinary steroid metabolites, tetrahydrocortisone, cortisone, androgen production, 24-hour urinary excretion
- MeSH terms
- Adrenal Cortex Hormones, Adult, Androgens, Cross-Sectional Studies, Female, Humans, Hydrocortisone, Insulin, Insulin Resistance, Polycystic Ovary Syndrome, 3-Oxo-5-alpha-Steroid 4-Dehydrogenase, Body Mass Index, 11-beta-Hydroxysteroid Dehydrogenase Type 1, 20-alpha-Hydroxysteroid Dehydrogenase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.